[go: up one dir, main page]

UA98500C2 - Substituted acylanilides and methods of use thereof - Google Patents

Substituted acylanilides and methods of use thereof

Info

Publication number
UA98500C2
UA98500C2 UAA201000541A UAA201000541A UA98500C2 UA 98500 C2 UA98500 C2 UA 98500C2 UA A201000541 A UAA201000541 A UA A201000541A UA A201000541 A UAA201000541 A UA A201000541A UA 98500 C2 UA98500 C2 UA 98500C2
Authority
UA
Ukraine
Prior art keywords
methods
disorder
substituted acylanilides
acylanilides
substituted
Prior art date
Application number
UAA201000541A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Джеймс Т. Далтон
Дуэйн Д. Миллер
Original Assignee
Юнивэрсити Оф Тэннэсси Рисэрч Фаундэйшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнивэрсити Оф Тэннэсси Рисэрч Фаундэйшн filed Critical Юнивэрсити Оф Тэннэсси Рисэрч Фаундэйшн
Priority claimed from PCT/US2007/015895 external-priority patent/WO2008008433A2/en
Publication of UA98500C2 publication Critical patent/UA98500C2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

This invention provides substituted acylanilide compounds and uses thereof in treating a variety of diseases or conditions in a subject, including, inter alia, a muscle wasting disease and/or disorder or a bone-related disease and/or disorder.
UAA201000541A 2006-07-12 2007-07-12 Substituted acylanilides and methods of use thereof UA98500C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83015806P 2006-07-12 2006-07-12
PCT/US2007/015895 WO2008008433A2 (en) 2006-07-12 2007-07-12 Substituted acylanilides and methods of use thereof

Publications (1)

Publication Number Publication Date
UA98500C2 true UA98500C2 (en) 2012-05-25

Family

ID=52280775

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201000541A UA98500C2 (en) 2006-07-12 2007-07-12 Substituted acylanilides and methods of use thereof

Country Status (1)

Country Link
UA (1) UA98500C2 (en)

Similar Documents

Publication Publication Date Title
MX2009000385A (en) Substituted acylanilides and methods of use thereof.
MX2009001962A (en) Substituted acylanilides and methods of use thereof.
EA011306B8 (en) Selective androgen receptor modulators and methods of use thereof
MX2010004219A (en) Cd19 binding agents and uses thereof.
WO2008011072A3 (en) Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof
TNSN07111A1 (en) Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity.
IL201792A (en) Multivalent polypeptides, compounds or constructs directed against rank-l for the treatment of bone diseases and disorders
MY149630A (en) Antibodies against amyloid-beta peptide
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
TW200738270A (en) Method of treating depression using a TNFα antibody
SG135192A1 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2008022024A3 (en) Imidazole amines as inhibitors of beta-secretase
ATE542823T1 (en) 4,5-DIHYDRO-Ä1,2,4ÜTRIAZOLOÄ4,3-FÜPTERIDINE AS A PLK1 PROTEIN KINASE INHIBITOR FOR THE TREATMENT OF PROLIFERATIVE DISEASES
IL187085A0 (en) Combination therapy comprising diaryl ureas for treating diseases
PL1793842T3 (en) Treatment for cancer-related fatigue
LTC2805723I2 (en) CLADRIBIN REGIME FOR THE TREATMENT OF MULTIPLE SCLEROSIS
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
PT2056805E (en) USE OF 2.5-DI-HYDROXYBENZENE DERIVATIVES FOR THE TREATMENT OF TISSUE REACTION
GB0410399D0 (en) The treatment of respiratory disease
IL178815A0 (en) The treatment of respiratory disease
MX2010000956A (en) Compounds which inhibit beta-secretase activity and methods of use thereof.
MX2009009693A (en) Methods of activating irs-1 and akt.
UA101961C2 (en) CRYSTALLINE FORM 1 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE$CRYSTALLINE FORM 1 2-((R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
MX2010001303A (en) Therapeutic compounds.